SCHEMBL7344628

SCHEMBL7344628

COc1cc(C)c2nc(Cl)[nH]c2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NUDT1 P36639 1/20 0.41
ALDH1A1 P00352 3/20 0.39
LMNA P02545 1/20 0.39
HPGD P15428 1/20 0.39
MGAM O43451 2/20 0.37
GAA P10253 2/20 0.37
SI P14410 2/20 0.37
MGAM2 Q2M2H8 2/20 0.37
KDM4E B2RXH2 3/20 0.36
POLB P06746 1/20 0.36
HTT P42858 1/20 0.35
AXL P30530 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35
DYRK1A Q13627 2/20 0.35
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
ADORA3 P0DMS8 1/20 0.33
ADORA1 P30542 1/20 0.33
PDE10A Q9Y233 2/20 0.33
CYP1A2 P05177 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10288043 0.82 HTT (0.44) NUDT1ALDH1A1LMNAMGAMGAA
SCHEMBL4283192 0.78 ESR1 (0.41) NUDT1MGAMGAASIMGAM2
SCHEMBL5695130 0.77 CYP2E1 (0.39) ALDH1A1HPGDMGAMGAASI
SCHEMBL7344632 0.72 PDE3B (0.39) ALDH1A1LMNAKDM4EPOLBAXL
SCHEMBL7341936 0.72 ACHE (0.39) NUDT1ALDH1A1HPGDHTTNPC1
SCHEMBL24549176 0.70 HTT (0.43) ALDH1A1HPGDHTTNPC1RAB9A
SCHEMBL1748047 0.70 NPC1 (0.58) ALDH1A1LMNAHPGDKDM4EPOLB
SCHEMBL7345385 0.69 RAB9A (0.45) ALDH1A1LMNAHPGDMGAMGAA
SCHEMBL8294768 0.68 SIRT2 (0.47) ALDH1A1HPGDKDM4EPOLBNPC1
SCHEMBL21642520 0.68 ALDH1A1 (0.41) ALDH1A1LMNAKDM4EPOLBNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5436240-A Schizophrenia, Parkinson's disease, depression or hypotensive agents using tricyclic amines THE UPJOHN COMPANY (US) 1995-07-25 US disclosed
EP-0480939-B1 HETEROCYCLIC AMINES HAVING CENTRAL NERVOUS SYSTEM ACTIVITY UPJOHN CO (US) 1995-01-25 EP disclosed
US-5273975-A Heterocyclic amines having central nervous system activity THE UPJOHN COMPANY (US) 1993-12-28 US disclosed
EP-0480939-A1 HETEROCYCLIC AMINES HAVING CENTRAL NERVOUS SYSTEM ACTIVITY. UPJOHN CO (US) 1992-04-22 EP disclosed
WO-1990015058-A1 HETEROCYCLIC AMINES HAVING CENTRAL NERVOUS SYSTEM ACTIVITY THE UPJOHN COMPANY (US) 1990-12-13 WO disclosed